SCHEMBL8886587

SCHEMBL8886587

CCOC(=O)c1cnc2cccc(/C=C/P(=O)(OCC)OCC)n12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 5/20 0.43
TGFBR1 P36897 1/20 0.41
GAA P10253 3/20 0.36
NPC1 O15118 1/20 0.35
MAPT P10636 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CYP1A2 P05177 3/20 0.35
KDM4E B2RXH2 3/20 0.34
ALDH1A1 P00352 2/20 0.34
PIK3CD O00329 1/20 0.34
PIK3R1 P27986 1/20 0.34
PIK3CA P42336 1/20 0.34
PIK3CB P42338 1/20 0.34
PIK3CG P48736 1/20 0.34
GLA P06280 2/20 0.34
CYP3A4 P08684 2/20 0.33
GABRA1 P14867 2/20 0.33
GABRB2 P47870 2/20 0.33
CYP11B1 P15538 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8886598 1.00 IDO1 (0.43) IDO1TGFBR1GAANPC1MAPT
SCHEMBL8607489 0.81 IDO1 (0.46) IDO1TGFBR1GAANPC1MAPT
SCHEMBL8607817 0.79 IDO1 (0.43) IDO1TGFBR1GAANPC1MAPT
SCHEMBL8607762 0.76 IDO1 (0.41) IDO1TGFBR1GAANPC1MAPT
SCHEMBL8607204 0.76 IDO1 (0.50) IDO1TGFBR1GAANPC1MAPT
SCHEMBL8889403 0.76 GAA (0.60) GAANPC1MAPTRAB9ASMN1; SMN2
SCHEMBL8889397 0.76 GAA (0.60) GAANPC1MAPTRAB9ASMN1; SMN2
SCHEMBL7875409 0.76 GAA (0.51) IDO1TGFBR1GAANPC1MAPT
SCHEMBL8607413 0.75 POLB (0.44) IDO1TGFBR1GAANPC1MAPT
SCHEMBL7872427 0.74 IDO1 (0.46) IDO1TGFBR1GAANPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0436831-A2 Imidazo[1,2-a]pyridinylalkyl compounds for treatment of neurotoxic injury G.D. Searle & Co. (US) 1991-07-17 EP claimed
WO-1991008211-A1 IMIDAZO[1,2-a]PYRIDINYLALKYL COMPOUNDS FOR TREATMENT OF NEUROTOXIC INJURY G.D. SEARLE & CO. (US) 1991-06-13 WO claimed
US-5633237-A Imidazo[1,2-a]pyridinylalkyl phosphonic acid compounds for treatment of neurotoxic injury G.D. SEARLE & CO. (US) 1997-05-27 US disclosed
US-5360796-A Treatment of hypoxia, anoxia or ischemia G. D. SEARLE & CO. (US) 1994-11-01 US disclosed
EP-0436831-A2 Imidazo[1,2-a]pyridinylalkyl compounds for treatment of neurotoxic injury G.D. Searle & Co. (US) 1991-07-17 EP disclosed
WO-1991008211-A1 IMIDAZO[1,2-a]PYRIDINYLALKYL COMPOUNDS FOR TREATMENT OF NEUROTOXIC INJURY G.D. SEARLE & CO. (US) 1991-06-13 WO disclosed